Accessibility links

4 things to know about the newly approved sunscreen ingredient The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. It's been used for decades in Europe and Asia.

Health

4 things to know about the new sunscreen ingredient the FDA approved

June 13, 20268:00 AM ET

Maria Godoy at NPR headquarters in Washington, D.C., May 22, 2018. (photo by Allison Shelley) (Square)

Maria Godoy

Close-up of hands applying sun cream under a bright blue sky in Maldives

A sunscreen ingredient used in Europe and Asia that blocks UVA and UVB rays has been approved for use in the U.S. mihailomilovanovic/iStockphoto/Getty Images hide caption

toggle caption

mihailomilovanovic/iStockphoto/Getty Images

For the first time in nearly three decades, the Food and Drug Administration approved a new chemical UV filter for use in sunscreens sold in the U.S. And that has many dermatologists cheering.

"This is a very big deal," says Dr. Heather Rogers, a dermatologist in Seattle and a fellow of the American Academy of Dermatology.

Surveys show younger Americans doubt the safety of sunscreen. Misinformation on social media isn't helping.

Shots - Health News

Some TikTok influencers are maligning sunscreen. Here's what to know about the claims

The new ingredient is called bemotrizinol, and it has several advantages over the chemical sunscreen ingredients previously available in the U.S., Rogers says.

"It hits like really every box for us that we have been waiting for as dermatologists and consumers," Rogers says.

Here's what you need to know about this new ingredient and how it could lead to better sunscreens sold stateside.

1. It blocks both UVA and UVB rays

Rogers says in general, you want to use sunscreens that are broad spectrum, meaning they protect against both UVA rays – the longer wavelengths that cause premature aging and wrinkles – and UVB rays, which lead to sunburns. Both types of UV rays can cause skin cancer.

She says the sunscreens currently sold in the U.S. do an excellent job of protecting against UVB rays, but the chemical UV filters available in sunscreens in the U.S. until now aren't as good at blocking out UVA rays.

Want the latest stories on the science of healthy living? Subscribe to NPR's Health newsletter .

In general, chemical sunscreens sold in the U.S. rely on an ingredient called avobenzone to block out UVA rays, says Kelly Dobos, a cosmetic chemist who teaches at the University of Cincinnati.

But avobenzone by itself isn't photo stable, meaning its protection can start to break down rapidly when exposed to sunlight. And as avobenzone breaks down, it can release molecules that lead to skin irritation, says Alexa Friedman, a senior scientist with the nonprofit Environmental Working Group, or EWG.

By contrast, bemotrizinol offers protection against both UVA and UVB rays all on its own, and it is photo stable, so it breaks down more slowly, offering better protection, Rogers says.

"So if you go a little longer than two hours to reapply your sunscreen, there will be more protection left," Rogers says. However, she says you should still reapply sunscreen every two hours.

2. It's long been used in other countries

Bemotrizinol has been widely used in European and Asian sunscreens for decades. But it has taken 20 years for the FDA to approve its use in this country.

That's because in the U.S., sunscreens are regulated as over-the-counter drugs rather than cosmetics, as they're classified in Europe. That means ingredients need to undergo rigorous testing for safety and efficacy before they can be approved for use in the U.S.

"It's really expensive and time consuming," Dobos says. The European company DSM-Firmenich spent at least $18 million over more than two decades in its push to gain FDA approval for bemotrizinol.

3. It has a well-documented safety profile

However, all that testing means bemotrizinol has more safety data to back it up than any other chemical sunscreen ingredient currently approved in the U.S., says Friedman of EWG.

Picking the 'right' sunscreen isn't as important as avoiding these 6 mistakes

Shots - Health News

Picking the 'right' sunscreen isn't as important as avoiding these 6 mistakes

"This ingredient is exciting because we have that data to support its safety," Friedman says.

Friedman says animal testing showed bemotrizinol doesn't lead to concerns like reproductive harm, while clinical testing on humans found that it does not irritate the skin, even after repeated application over time, "which is hopefully how people are using sunscreens."

And because bemotrizinol's molecules are larger, it's not readily absorbed by the skin and into the bloodstream, she says.

That's important, because studies have shown that some of the other chemical sunscreen UV filters sold in the U.S. can be absorbed in the bloodstream, prompting calls for more safety data and leading to a backlash against sunscreen on social media fueled by misinformation. Rogers says that trend is concerning because skin cancer is the most common form of cancer.

"We just need to have sunscreen that people will use, that they'll trust," Rogers says. "And this ingredient is going to allow that to happen. And that is very exciting."

And bemotrizinol is also considered to be non-irritating, Friedman says. That should be welcome news to people who've been put off by chemical sunscreens in the past.

4. It could lead to sunscreens that look better on you

Until now, Rogers says, the only sunscreen ingredient available in the U.S. that offered the aforementioned advantages of bemotrizinol – photo stable, non-irritating, minimally absorbed into the skin and with good broad spectrum protection against both UVA and UVB rays – was zinc oxide.

Both zinc oxide and titanium dioxide are mineral UV filters. Both chemical sunscreens and mineral sunscreens work by absorbing UV rays from the sun. Mineral sunscreens also reflect some UV rays. The bigger difference is that mineral sunscreens sit on the surface of the skin, while chemical sunscreens get absorbed into the skin, Rogers says.

A dark skinned hand squeezes sunscreen from a white and teal plastic tube with an orange top into their hand. At the very right hand side of the image a sliver of the back of someone's head is visible, someone with longer dark hair. In the left half of the image in the blurred background is a what looks to be a teal shirt. The image is beneath the words Short Wave, in white letters at the top of the image. The words are above half of a yellow and orange cartoon wave.

Short Wave

U.S. sunscreens haven't been updated for decades – but the science has

The downside of mineral sunscreens is that they can leave an unattractive white cast on the skin – think of lifeguards with white paste on their noses. "Particularly if you're a person of color, zinc is going to make you look pale, white or ashy, which really makes it hard to use on a regular basis," Rogers says.

Bemotrizinol, on the other hand, is transparent on the skin, and because it protects against both UVA and UVB rays on its own, it doesn't have to be mixed with as many other chemical filters and stabilizers to achieve broad spectrum protection, Dobos adds. She says that should lead to more aesthetically pleasing, less greasy sunscreen formulations in the near future.

"I think it's a real win for public health," Dobos says. "If we can make a sunscreen that consumers like to use and want to use and apply in the proper amounts, I think that's something that's really going to be a win for consumers."

DSM-Firmenich has exclusive rights to market bemotrizinol in the U.S. for 18 months. It will be sold under the brand name Parsol Shield. The company says the first sunscreen products containing the ingredient should start hitting American store shelves around September.

NPR Plus logo

Exclusive benefits
Give a little. Get a lot.

Support mission-driven journalism while getting something great in return. Enjoy bonus content, early access and sponsor-free listening from your favorite NPR podcasts.

Get NPR+

Already have NPR+? Sign In

Close modal

a11107397707.cdn.optimizely.com

a11107397707.cdn.optimizely.com is blocked

This page has been blocked by an extension

  • Try disabling your extensions.

ERR_BLOCKED_BY_CLIENT

Reload

This page has been blocked by an extension

NPR logo

Privacy Preference Center

NPR and our service providers and vendors use cookies and similar technologies to collect information. A cookie is a string of characters that can be written to a file on the user's computer or device when the user visits a site, application, platform or service. When you visit a website or use a mobile application, a computer asks your computer or mobile device for permission to store this file on your computer or mobile device and access information from it. Information gathered through cookies may include the date and time of visits and how you are using the website. Note that if you disable or delete cookies, you may lose access to certain features of the NPR Services.

User ID: 75888849-65a5-4903-815b-a46931237b05

This User ID will be used as a unique identifier while storing and accessing your preferences for future.

Timestamp: --

Allow All

Manage Consent Preferences

Strictly Necessary or Essential Cookies

Always Active

These cookies are essential to provide you with services available through the NPR Services and to enable you to use some of their features. For example, these cookies allow NPR to remember your registration information while you are logged in. Local station customization, the NPR Shop, and other interactive features also use cookies. Without these cookies, the services that you have asked for cannot be provided, and we only use these cookies to provide you with those services.

Performance and Analytics Cookies

Performance and Analytics Cookies

These cookies are used to collect information about traffic to our Services and how users interact with the NPR Services. The information collected includes the number of visitors to the NPR Services, the websites that referred visitors to the NPR Services, the pages that they visited on the NPR Services, what time of day they visited the NPR Services, whether they have visited the NPR Services before, and other similar information. We use this information to help operate the NPR Services more efficiently, to gather broad demographic information and to monitor the level of activity on the NPR Services.

Functional Cookies

Functional Cookies

These cookies allow our Services to remember choices you make when you use them, such as remembering your Member station preferences and remembering your account details. The purpose of these cookies is to provide you with a more personal experience and to prevent you from having to re-enter your preferences every time you visit the NPR Services.

Targeting and Sponsor Cookies

Targeting and Sponsor Cookies

These cookies track your browsing habits or other information, such as location, to enable us to show sponsorship credits which are more likely to be of interest to you. These cookies use information about your browsing history to group you with other users who have similar interests. Based on that information, and with our permission, we and our sponsors can place cookies to enable us or our sponsors to show sponsorship credits and other messages that we think will be relevant to your interests while you are using third-party services.

Back Button

Cookie List

Search Icon

Filter Icon

Clear

  • checkbox labellabel

ApplyCancel

ConsentLeg.Interest

checkbox labellabel

checkbox labellabel

checkbox labellabel

Reject AllConfirm My Choices

Powered by Onetrust

Read Original at NPR